Medicinal Chemistry Core
Medicinal Chemistry Core
批准号:
10649658
负责人:
ROBERT H MACH
金额:
$131.6万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-24 至 2024-06-30
关键词:
ABCB1 geneAffinityAlzheimer&aposs DiseaseBasic ScienceBindingBinding SitesBiological AssayBrainCollaborationsComputer ModelsDevelopmentDockingEvaluationFilamentFrontotemporal DementiaGoalsHigh Pressure Liquid ChromatographyImageIn VitroIndividualInstitutionLeadLigandsMeasurementMeasuresMethodsMonitorMultiple System AtrophyOctanolsParalysedParkinson DiseasePartition CoefficientPatientsPennsylvaniaPharmaceutical ChemistryPositron-Emission TomographyPropertyProtein ChemistryRadiochemistryRadiolabeledResearchResearch ContractsResearch PersonnelResearch Project GrantsSeriesSiteSpecificityStructureStructure-Activity RelationshipTauopathiesTeleconferencesTestingTissuesUniversitiesWashingtonWateralpha synucleinanalogbrain tissueclinical imaginghigh throughput screeningimaging agentimaging studyin silicoin vitro Assayin vivoinnovationlipophilicitymembermolecular dynamicsmultidisciplinarynovelradioligandradiotracerscale upscreeningsmall moleculestructural biologytargeted agenttau Proteinsuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
MEDICINAL CHEMISTRY AND RADIOCHEMISTRY CORE ABSTRACT
The Medicinal Chemistry and Radiochemistry (MCRC) Core represents the central hub of activity of this
U19 Center. The initial focus of the MCRC Core is the use of novel in silico methods for the identification
of lead compounds for PET radiotracer development for alpha synuclein (Asyn) and 4R tau. This
approach to lead compound identification is highly innovative since it has never been applied prior to this
in the field of PET radiotracer development. Once in silico hits have been confirmed as true lead
compounds from the radioligand binding studies conducted in Projects 1 and 2, the MCRC Core will be
responsible for conducting structure-activity relationship (SAR) studies to identify compounds having the
appropriate properties for radiolabeling and additional in vitro and in vivo characterization. The
radiolabeling studies will be conducted by the radiochemistry component of the MCRC Core.
There are four different sites involved in the MCRC Core, the University of Pennsylvania, Washington
University-St. Louis, the University of Pittsburgh, and the contract research organization, MedChem
Imaging. The Core Co-Directors are Drs. Robert H. Mach and E. James Petersson of Penn; each site
will also have a site P.I. (C. Mathis, Pitt; Z. Tu, Wash U; Neil Vasdev, MedChem Imaging). The site P.I.s
will serve as members of the Executive Steering Committee, who will meet via video teleconference on
a bi-weekly basis. The goal of the Executive Steering Committee is to monitor progress of the in silico
screening methods and in vitro binding studies, and the determination of which group should be assigned
the resultant SAR studies on the true lead compounds. Another goal of the MCRC Core is to conduct an
in vitro assay to determine if promising compounds are substrates for P-glycoprotein. A final function of
the MCRC Core is to conduct scale-up synthesis of precursors and standards required for the imaging
studies conducted by the Clinical Imaging Core.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ConProject-005
-
批准号:10364583
-
项目类别:
-
资助金额:$17.22万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Radiochemistry Core
-
批准号:10449223
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
In Vitro and In Vivo Characterization of Alpha-Synuclein PET Radiotracers
-
批准号:10241512
-
项目类别:
-
资助金额:$104.57万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Medicinal Chemistry Core
-
批准号:10241510
-
项目类别:
-
资助金额:$166.2万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)
-
批准号:10613207
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Administrative Core
-
批准号:10649657
-
项目类别:
-
资助金额:$40.84万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
In Vitro and In Vivo Characterization of Alpha-Synuclein PET Radiotracers
-
批准号:10023219
-
项目类别:
-
资助金额:$106.94万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
ConProject-006
-
批准号:10364584
-
项目类别:
-
资助金额:$3.21万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Radiochemistry Core
-
批准号:10201546
-
项目类别:
-
资助金额:$36.93万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Administrative Core
-
批准号:10449221
-
项目类别:
-
资助金额:$24.34万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)
-
批准号:10649656
-
项目类别:
-
资助金额:$397.46万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Administrative Core
-
批准号:10201544
-
项目类别:
-
资助金额:$36.93万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
In Vitro and In Vivo Characterization of Alpha-Synuclein PET Radiotracers
-
批准号:10649664
-
项目类别:
-
资助金额:$85.57万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)
-
批准号:10023208
-
项目类别:
-
资助金额:$420.35万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Administrative Core
-
批准号:10023216
-
项目类别:
-
资助金额:$43.68万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Medicinal Chemistry Core
-
批准号:10023217
-
项目类别:
-
资助金额:$175.99万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)
-
批准号:10241508
-
项目类别:
-
资助金额:$427.93万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
Administrative Core
-
批准号:10241509
-
项目类别:
-
资助金额:$41.14万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
ConProject-004
-
批准号:10364582
-
项目类别:
-
资助金额:$21.55万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
ConProject-008
-
批准号:10364586
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2019
-
负责人:ROBERT H MACH
-
依托单位:
海外基金